Indaptus Therapeutics, Inc. (INDP) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$14.82M | -20.3% |
| 2024 | -$12.32M | +8.1% |
| 2023 | -$13.41M | -2.5% |
| 2022 | -$13.08M | -15.8% |
| 2021 | -$11.29M | -239.6% |
| 2020 | -$3.32M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$14.82M | -20.3% |
| 2024 | -$12.32M | +8.1% |
| 2023 | -$13.41M | -2.5% |
| 2022 | -$13.08M | -15.8% |
| 2021 | -$11.29M | -239.6% |
| 2020 | -$3.32M | — |